Chemed Co. (NYSE:CHE) Shares Sold by William Allan Corp

William Allan Corp decreased its position in shares of Chemed Co. (NYSE:CHE) by 0.3% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 7,351 shares of the company’s stock after selling 23 shares during the quarter. Chemed comprises 2.7% of William Allan Corp’s holdings, making the stock its 15th biggest position. William Allan Corp’s holdings in Chemed were worth $4,418,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Crawford Fund Management LLC acquired a new stake in Chemed in the third quarter valued at $4,297,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Chemed by 7.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 45,920 shares of the company’s stock worth $27,597,000 after purchasing an additional 3,314 shares during the last quarter. Townsquare Capital LLC purchased a new stake in Chemed during the third quarter worth $4,115,000. BNP Paribas Financial Markets grew its holdings in Chemed by 36.2% in the third quarter. BNP Paribas Financial Markets now owns 26,381 shares of the company’s stock valued at $15,854,000 after purchasing an additional 7,007 shares during the last quarter. Finally, FMR LLC increased its position in shares of Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after buying an additional 45,917 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director George J. Walsh III sold 400 shares of the stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This trade represents a 11.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,113 shares of company stock valued at $3,557,445 over the last 90 days. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Performance

CHE stock opened at $571.31 on Friday. The company has a 50 day moving average price of $578.45 and a two-hundred day moving average price of $565.06. The stock has a market capitalization of $8.60 billion, a P/E ratio of 28.87, a PEG ratio of 2.42 and a beta of 0.46. Chemed Co. has a one year low of $523.33 and a one year high of $654.62.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same period last year, the company posted $5.32 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. Research analysts forecast that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s payout ratio is currently 10.11%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CHE. Royal Bank of Canada dropped their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Friday, November 22nd.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.